dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Picón, Carmen |
dc.contributor.author | Tejeda-Velarde, Amalia |
dc.contributor.author | Fernández-Velasco, José Ignacio |
dc.contributor.author | Álvarez-Lafuente, Roberto |
dc.contributor.author | Quintana, Ester |
dc.contributor.author | Matute Blanch, Clara |
dc.contributor.author | Espejo Ruiz, Carmen |
dc.contributor.author | Comabella Lopez, Manuel |
dc.date.accessioned | 2022-03-23T12:14:58Z |
dc.date.available | 2022-03-23T12:14:58Z |
dc.date.issued | 2021-07 |
dc.identifier.citation | Picón C, Tejeda-Velarde A, Fernández-Velasco JI, Comabella M, Álvarez-Lafuente R, Quintana E, et al. Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis. Front Immunol. 2021 Jul;12:685139. |
dc.identifier.issn | 1664-3224 |
dc.identifier.uri | https://hdl.handle.net/11351/7254 |
dc.description | Immunitat adaptativa; Envelliment; Esclerosi múltiple |
dc.description.sponsorship | This work was supported by grants FIS-PI15/00513, FIS-PI18/00572 and RD16/0015/0001 from the Instituto de Salud Carlos III. Ministerio de Ciencia e Innovación, Spain and FEDER: "Una manera de hacer Europa". |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Immunology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Esclerosi múltiple - Tractament |
dc.subject | Envelliment - Aspectes immunològics |
dc.subject.mesh | Multiple Sclerosis |
dc.subject.mesh | /immunology |
dc.subject.mesh | Immunosenescence |
dc.title | Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fimmu.2021.685139 |
dc.subject.decs | esclerosis múltiple |
dc.subject.decs | /inmunología |
dc.subject.decs | inmunosenescencia |
dc.relation.publishversion | https://doi.org/10.3389/fimmu.2021.685139 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Picón C] Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain. Department of Brain Science, Imperial College London, London, United Kingdom. [Tejeda-Velarde A, Fernández-Velasco JI] Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain. [Comabella M, Matute-Blanch C, Espejo C] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Álvarez-Lafuente R] Department of Neurology, Hospital Clínico San Carlos, Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), REEM, Madrid, Spain. [Quintana E] Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr. Josep Trueta, Institut d’Investigació Biomèdica de Girona (IDIBGI), Girona, Medical Sciences Department, Universitat de Girona, REEM, Girona, Spain |
dc.identifier.pmid | 34322119 |
dc.identifier.wos | 000679208500001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |